PIS
GMAB icon

POM Investment Strategies’s Genmab GMAB Stock Holding History

POM Investment Strategies’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14
Closed -$274 – 182
2025
Q1 		$274 Hold
14
– – ﹤0.01% 205
2024
Q4 		$292 Hold
14
– – ﹤0.01% 330
2024
Q3 		$341 Hold
14
– – ﹤0.01% 288
2024
Q2 		$352 Hold
14
– – ﹤0.01% 312
2024
Q1 		$419 Hold
14
– – ﹤0.01% 235
2023
Q4 		$446 Buy
+14
New +$440 ﹤0.01% 222

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

POM Investment Strategies's GMAB Position: Q2 2025 in Review

POM Investment Strategies sold out of Genmab (GMAB) in Q2 2025, closing a stake of 14 shares — an estimated $274 sold.

POM Investment Strategies first reported a position in GMAB in Q4 2023 and held it in 6 quarters. The position peaked at $446 in Q4 2023. 218 funds tracked by Wall St. Rank hold GMAB as of Q2 2025.

  • POM Investment Strategies reported no remaining Genmab position as of Q2 2025 after selling out during the quarter.
  • POM Investment Strategies sold 14 Genmab shares in Q2 2025, an estimated $274.
  • POM Investment Strategies first reported a position in Genmab in Q4 2023 and held it in 6 quarters.
  • POM Investment Strategies's Genmab position peaked at $446 in Q4 2023.
  • 218 funds tracked by Wall St. Rank held Genmab as of Q2 2025.

Based on POM Investment Strategies's 13F filing for Q2 2025, filed 8 Aug 2025.